NasdaqGS:MBLY
NasdaqGS:MBLYAuto Components

Mobileye Global (NasdaqGS:MBLY) Welcomes Patrick Bombach to Board as Stock Dips 13%

Mobileye Global (NasdaqGS:MBLY) recently welcomed Patrick Bombach to its Board of Directors, an event that adds to the evolving governance of the company. Despite this leadership change, Mobileye Global's stock price fell 13% over the past month, coinciding with broader market turbulence. U.S. tariffs impacting tech and consumer sectors and significant market drops likely pressured the company's performance. The Dow, S&P 500, and Nasdaq all experienced sharp declines, with tech stocks, in...
NasdaqCM:BTDR
NasdaqCM:BTDRSoftware

Bitdeer Technologies Group (NasdaqCM:BTDR) Sees 14% Dip After US$532 Million Net Loss Announced

Bitdeer Technologies Group (NasdaqCM:BTDR) announced significant developments last week, including Q4 2024 results revealing a substantial net loss of USD 532 million, a stark contrast from the previous year, potentially influencing its 13.59% share price decline. Additionally, the company's announcement of a USD 20 million share repurchase program seems to have offered limited immediate reassurance to investors amidst the broader market downturn. The financial report reflected declining...
NasdaqGM:IVVD
NasdaqGM:IVVDBiotechs

Invivyd (NasdaqGM:IVVD) Jumps 163% After Promising Phase 1/2 Trial Results For COVID-19 Antibody

Invivyd (NasdaqGM:IVVD) has seen its share price surge by an impressive 163% over the past month, driven primarily by the positive data released from its Phase 1/2 clinical trial of VYD2311, a novel monoclonal antibody candidate against COVID-19. The clinical trial results highlighted improved efficacy and a favorable safety profile, sparking investor enthusiasm amid market conditions characterized by significant volatility due to newly imposed U.S. tariffs. While major indices like the Dow...
NasdaqCM:SRTS
NasdaqCM:SRTSMedical Equipment

Sensus Healthcare (NasdaqCM:SRTS) Shares Dip 14% After Q4 Earnings Show US$3 Million Net Income Drop

Sensus Healthcare (NasdaqCM:SRTS) recently disclosed fourth-quarter 2024 earnings, revealing a slight rise in sales to USD 13.07 million compared to the previous year, despite a notable decrease in net income from USD 4.21 million to USD 1.55 million. This earnings announcement, coupled with expected lower sales in Q1 2025 relative to Q1 2024, presents a cautious outlook. Over the past week, the company's shares fell 14.07%, potentially influenced by broader market pressures as the Dow Jones...
NYSE:TDW
NYSE:TDWEnergy Services

Tidewater (NYSE:TDW) Stock Slides 19% Following Decline In Q4 2024 Net Income To US$37 Million

Tidewater (NYSE:TDW) faced a challenging week, with its stock price dropping 18.8%. This decline coincided with the company's recent earnings announcement, where it reported a decline in Q4 2024 net income to $36.91 million despite revenue growth. Tidewater's cautious earnings guidance for 2025, projecting revenues between $1.32 billion and $1.38 billion, may have fueled investor apprehension during the period. The strategic shift towards value-accretive acquisitions and increased share...